Metabolic impairment in heart failure

the myocardial and systemic perspective

Wolfram Doehner, Michael Frenneaux, Stefan D Anker

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Although bioenergetic starvation is not a new concept in heart failure (HF), recent research has led to a growing appreciation of the complexity of metabolic aspects of HF pathophysiology. All steps of energy extraction, transfer, and utilization are affected, and structural metabolism is impaired, leading to compromised functional integrity of tissues. Not only the myocardium, but also peripheral tissues and organs are affected by metabolic failure, resulting in a global imbalance between catabolic and anabolic signals, leading to tissue wasting and, ultimately, to cachexia. Metabolic feedback signals from muscle and fat actively contribute to further myocardial strain, promoting disease progression. The prolonged survival of patients with stable, compensated HF will increasingly bring chronic metabolic complications of HF to the fore and gradually shift its clinical presentation. This paper reviews recent evidence on myocardial and systemic metabolic impairment in HF and summarizes current and emerging therapeutic concepts with specific metabolic targets.

Original languageEnglish
Pages (from-to)1388-1400
Number of pages13
JournalJournal of the American College of Cardiology
Volume64
Issue number13
Early online date22 Sep 2014
DOIs
Publication statusPublished - 30 Sep 2014

Fingerprint

Heart Failure
Cachexia
Energy Transfer
Starvation
Energy Metabolism
Disease Progression
Myocardium
Fats
Muscles
Survival
Research
Therapeutics

Keywords

  • Cachexia
  • Disease Progression
  • Energy Metabolism
  • Growth Hormone
  • Heart Failure
  • Humans
  • Insulin Resistance
  • Muscle, Skeletal
  • Myocardium
  • Prognosis
  • Sarcopenia
  • Steroids
  • Stroke

Cite this

Metabolic impairment in heart failure : the myocardial and systemic perspective. / Doehner, Wolfram; Frenneaux, Michael; Anker, Stefan D.

In: Journal of the American College of Cardiology, Vol. 64, No. 13, 30.09.2014, p. 1388-1400.

Research output: Contribution to journalArticle

Doehner, Wolfram ; Frenneaux, Michael ; Anker, Stefan D. / Metabolic impairment in heart failure : the myocardial and systemic perspective. In: Journal of the American College of Cardiology. 2014 ; Vol. 64, No. 13. pp. 1388-1400.
@article{bffeed8c045745468bd333256c366f92,
title = "Metabolic impairment in heart failure: the myocardial and systemic perspective",
abstract = "Although bioenergetic starvation is not a new concept in heart failure (HF), recent research has led to a growing appreciation of the complexity of metabolic aspects of HF pathophysiology. All steps of energy extraction, transfer, and utilization are affected, and structural metabolism is impaired, leading to compromised functional integrity of tissues. Not only the myocardium, but also peripheral tissues and organs are affected by metabolic failure, resulting in a global imbalance between catabolic and anabolic signals, leading to tissue wasting and, ultimately, to cachexia. Metabolic feedback signals from muscle and fat actively contribute to further myocardial strain, promoting disease progression. The prolonged survival of patients with stable, compensated HF will increasingly bring chronic metabolic complications of HF to the fore and gradually shift its clinical presentation. This paper reviews recent evidence on myocardial and systemic metabolic impairment in HF and summarizes current and emerging therapeutic concepts with specific metabolic targets.",
keywords = "Cachexia, Disease Progression, Energy Metabolism, Growth Hormone, Heart Failure, Humans, Insulin Resistance, Muscle, Skeletal, Myocardium, Prognosis, Sarcopenia, Steroids, Stroke",
author = "Wolfram Doehner and Michael Frenneaux and Anker, {Stefan D}",
note = "Copyright {\circledC} 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.",
year = "2014",
month = "9",
day = "30",
doi = "10.1016/j.jacc.2014.04.083",
language = "English",
volume = "64",
pages = "1388--1400",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "13",

}

TY - JOUR

T1 - Metabolic impairment in heart failure

T2 - the myocardial and systemic perspective

AU - Doehner, Wolfram

AU - Frenneaux, Michael

AU - Anker, Stefan D

N1 - Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

PY - 2014/9/30

Y1 - 2014/9/30

N2 - Although bioenergetic starvation is not a new concept in heart failure (HF), recent research has led to a growing appreciation of the complexity of metabolic aspects of HF pathophysiology. All steps of energy extraction, transfer, and utilization are affected, and structural metabolism is impaired, leading to compromised functional integrity of tissues. Not only the myocardium, but also peripheral tissues and organs are affected by metabolic failure, resulting in a global imbalance between catabolic and anabolic signals, leading to tissue wasting and, ultimately, to cachexia. Metabolic feedback signals from muscle and fat actively contribute to further myocardial strain, promoting disease progression. The prolonged survival of patients with stable, compensated HF will increasingly bring chronic metabolic complications of HF to the fore and gradually shift its clinical presentation. This paper reviews recent evidence on myocardial and systemic metabolic impairment in HF and summarizes current and emerging therapeutic concepts with specific metabolic targets.

AB - Although bioenergetic starvation is not a new concept in heart failure (HF), recent research has led to a growing appreciation of the complexity of metabolic aspects of HF pathophysiology. All steps of energy extraction, transfer, and utilization are affected, and structural metabolism is impaired, leading to compromised functional integrity of tissues. Not only the myocardium, but also peripheral tissues and organs are affected by metabolic failure, resulting in a global imbalance between catabolic and anabolic signals, leading to tissue wasting and, ultimately, to cachexia. Metabolic feedback signals from muscle and fat actively contribute to further myocardial strain, promoting disease progression. The prolonged survival of patients with stable, compensated HF will increasingly bring chronic metabolic complications of HF to the fore and gradually shift its clinical presentation. This paper reviews recent evidence on myocardial and systemic metabolic impairment in HF and summarizes current and emerging therapeutic concepts with specific metabolic targets.

KW - Cachexia

KW - Disease Progression

KW - Energy Metabolism

KW - Growth Hormone

KW - Heart Failure

KW - Humans

KW - Insulin Resistance

KW - Muscle, Skeletal

KW - Myocardium

KW - Prognosis

KW - Sarcopenia

KW - Steroids

KW - Stroke

U2 - 10.1016/j.jacc.2014.04.083

DO - 10.1016/j.jacc.2014.04.083

M3 - Article

VL - 64

SP - 1388

EP - 1400

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 13

ER -